PEPorter K. Ellis

Porter K. Ellis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Porter K. Ellis has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A phage-encoded GapR nucleoid-associated protein binds a bacterial GapR to deactivate it via an inhibitory hetero-oligomer mechanism

    by Maria A. Schumacher, Madeline B. Stodgell, Raul Salinas, Sunny Yadav, Katie Leung, Lucy M. Kwiatkowski, Porter K. Ellis, Hengshan Zhang, Monica S. Guo

    Nucleoid-associated proteins (NAPs) play key roles in bacterial chromosome organization and cellular processes. Recent work identified GapR as an essential NAP that is ubiquitous in α-proteobacteria. GapR structures revealed that the GapR dimer can form dimer of dimers in the presence of DNA to create a DNA-encasing clamp and data showed that GapR is required for bacterial replication as it recruits topoisomerases to regions of overtwisted DNA. Interestingly, diverse phages that infect α-proteobacteria encode GapR homologs. To gain insight into how phage GapRs may impact their cellular homologs we performed structure/function analyses on the Roseobacterial and Roseophage RDJLΦ1 GapR proteins. Crystal structures revealed that the RDJLΦ1 GapR structure differs from that of the bacterial GapR in a way that is incompatible with DNA binding. Cellular localization and fluorescence binding assays confirmed that the RDJLΦ1 phage GapR does not bind DNA. Strikingly, we show that the RDJLΦ1 GapR and Roseobacterial GapR can form heterodimers that are unable to bind DNA, suggesting the phage GapR may act as a bacterial GapR poison. This was further supported by cellular studies. Collectively these studies reveal a unique autoinhibitory mechanism by which a phage encoded NAP impacts DNA binding by the host NAP.

  • Open Access

    Mitochondrial cardiolipin sequestration of caspofungin underlies Cryptococcus neoformans inherent resistance and may contribute to cardiotoxicity

    by Anna K. Loksztejn, Rajendra Upadhya, Eduardo A. Caro, David M. Gooden, Adi Yona, Porter K. Ellis, Micha Fridman, Maria A. Schumacher, Richard G. Brennan, Maureen J. Donlin, et al.

    Cryptococcus exhibits inherent resistance to the echinocandin, caspofungin, which inhibits the synthesis of (1,3)-β-D-glucan, a key component of the polysaccharide cell wall. The essential FKS1 gene encodes the catalytic subunit of (1,3)-β-D-glucan synthase and caspofungin effectively inhibits its activity in vitro, yet the drug remains ineffective against Cryptococcus, suggesting mechanisms beyond target insensitivity. The underlying mechanisms of caspofungin resistance remain unknown, although altered regulation of cell-wall remodeling genes, plasma membrane modifications, drug efflux pathways, and melanin biosynthesis have been suggested. Using boron dipyrromethene (BD-) and fluorescein (F-) labelled caspofungin, we demonstrate that caspofungin enters the cryptococcal cell and primarily accumulates in the mitochondrial inner membrane rather than the plasma membrane. We further establish that this mitochondrial accumulation is driven by a specific interaction between caspofungin and cardiolipin, a phospholipid found in mitochondrial membranes. We demonstrate that this unforeseen localization indicates that mitochondrial sequestration diminishes the effective drug concentrations at the intended target. Notably, the interaction between caspofungin and cardiolipin also takes place in human cells, establishing a mechanistic connection to caspofungin-related cardiotoxicity. Our findings reveal a previously unrecognized mechanism of echinocandin resistance in Cryptococcus and emphasize cardiolipin as an important factor in caspofungin effectiveness.


  • Structural and Biophysical Characterization of the Yersinia Type Three Secretion System ATPase YscN

    by Samuel A. Barker, Porter K. Ellis, Andrew Hammer, Sean J. Johnson, Nicholas E. Dickenson

    Yersinia pestis was responsible for the Black Plague, one of the worst epidemiological disasters in recorded history. Today, Y. pestis , Y. enterocolitica , and Y. pseudotuberculosis remain clinically relevant human pathogens. Each of these pathogenic Yersinia species relies on a Type Three Secretion System (T3SS) for virulence, with the ATPase YscN playing a critical role in T3SS function. T3SS ATPases are responsible for powering apparatus formation and effector protein secretion through ATP hydrolysis. This study provides an extensive enzymatic characterization of recombinant YscN under several conditions, including variable pH and temperature, substrate and protein concentrations, and in the presence of putative inhibitors. Thermal stability data, assessed by circular dichroism, demonstrate that YscN exhibits increased stability in alkaline conditions, coinciding with greatest ATPase activity. Further, we report the first high‐resolution crystal structure of YscN and leverage homology data to model an oligomeric active site. Mutational analysis of a predicted active site residue confirms oligomerization as necessary for YscN ATPase activity and corroborates our oligomeric model and enzyme concentration‐dependent specific activity. Interestingly, however, AUC analysis reveals that the purified YscN predominantly exists as a monomer, despite oligomerization‐dependent active site formation. Thus, we propose that transient oligomeric interactions support the observed ATP hydrolysis. Together, these data uncover structural and environmental impacts on YscN activity that may support the highly specialized Yersinia pathogenic lifecycle and leverage its role in virulence in search of pan‐effective small molecule T3SS ATPase inhibitors.